Shangjing, the Li family's courtyard house.
Ye Yuan sat in a rosewood chair in the living room.
When he heard Dilai mention Notami's licensing rights,
he finally perked up.
Yet no matter how Dilai probed,
he gave only negative answers.
But how could Dilai give up so easily?
So he continued persuading him:
"But I heard that your renewed negotiations haven't gone smoothly.
In business, Ye!
Don't you think having one more competitor would be most beneficial to you?"
Dilai refused to give up and still wanted to secure Notami's overseas licensing rights.
"I'm truly sorry, but just yesterday, I agreed to an exchange condition proposed by the Ouyang Family.
So I think these negotiations will reach a conclusion very soon."
Ye Yuan also knew that if he did not reveal some information,
this fellow would never give up.
Since that was the case,
he might as well tell him the outcome.
Even if, in the worst-case scenario, he truly failed to reach an agreement with the Ouyang Family,
he would have Huangyuan Technology handle the overseas licensing rights.
He would not hand them directly to Dilai.
He had already considered that point before.
The reason he had sought out the Ouyang Family
was because they owned their own pharmaceutical company.
Huangyuan Technology, on the other hand, could only act as an agent.
Since Ye Yuan had not intended to make a profit,
he had ultimately chosen the more reliable Ouyang Family.
After all, Huangyuan Technology was already involved in enough fields.
He did not want Huangyuan Technology to draw too much attention.
Huangyuan Technology had already passed through its period of explosive growth.
At its current stage, what Huangyuan Technology needed was stability—consolidating its position in every industry.
This was also the conclusion Ye Yuan and Leonard had reached